Antidepressants, antiplatelets and bleeding: One more thing to worry about?

Juurlink, David N.
November 2011
CMAJ: Canadian Medical Association Journal;11/8/2011, Vol. 183 Issue 16, p1819
Academic Journal
In this article, the author discusses the use of antidepressants and antiplatelet drugs on patients. He focuses on the safety of such treatment as reseach about the drugs revealed high risk of hemorrhage on patients taking the drugs. The author suggests that patients who have experienced bleeding and have strong indication for selective serotonin reuptake inhibitor (SSRI) therapy should start avoiding the drugs.


Related Articles

  • SSRIs + antiplatelets increase bleeding risk after MI.  // Reactions Weekly;10/8/2011, Issue 1372, p4 

    The article discusses research on the risk of bleeding associated with selective serotonin reuptake inhibitors and antiplatelet therapy after acute myocardial infarction, referencing a study by C. Labos et al published in the September 26, 2011 issue of the "Canadian Medical Association Journal."

  • Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding. Walling, Anne D. // American Family Physician;4/1/2002, Vol. 65 Issue 7, p1435 

    Presents an abstract of the study 'Inhibition of Serotonin Reuptake by Antidepressants and Upper Gastrointestinal Bleeding in Elderly Patients: Retrospective Cohort Study,' by C. Van Walraven, et al, published in the September 22, 2001 issue of the 'British Medical Journal.

  • HEALTH.  // Women's Health;Oct2013, Vol. 10 Issue 8, p30 

    The article presents health related topics and issues. A study published in the "Journal of the American Medical Association Internal Medicine" found that antidepressants called selective serotonin reuptake inhibitors (SSRIs) may increase the risk for bleeding in patients who had surgery. A...

  • Patient compliance with SSRIs and tricyclic antidepressants.  // American Family Physician;10/1/1995, Vol. 52 Issue 5, p1563 

    Reports on a study from the June 3, 1995 issue of the `British Medical Journal,' by Anderson and Tomenson who conducted a meta-analysis comparing patient compliance rates associated with tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRI). Discontinuation of medication...

  • Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR. Maschino, Franck; Hurault-Delarue, Caroline; Chebbane, Leila; Fabry, Vincent; Montastruc, Jean; Bagheri, Haleh // European Journal of Clinical Pharmacology;Nov2012, Vol. 68 Issue 11, p1557 

    Aim: The aim of the present study was to investigate bleeding adverse drug reactions (ADRs) in patients exposed to serotonin reuptake inhibitors (SRI) plus antiplatelet agents using the French Pharmacovigilance Database (FPVDB) regarding the controversial data in the literature. Methods: The...

  • SSRIs raise warfarin risk.  // Pulse;5/13/2009, Vol. 69 Issue 16, p6 

    The article reports on the result of a study which explores the impact of selective serotonin reuptake inhibitors (SSRIs) on the risk of bleeding in patients on warfarin. The study found that SSRIs increase the risk of bleeding by more than three times compared to other antidepressants. The...

  • Fluoxetine, a selective serotonin reuptake inhibitor modulates inflammatory and neuropathic pain in the rat. Pal Singh, Vijay; Jain, Naveen K.; Kulkarni, S. K. // Inflammopharmacology;2002, Vol. 9 Issue 3, p219 

    The clinical usefulness of classical tricyclic antidepressants has been indicated in a variety of neuropathic pain. The role of selective serotonin reuptake inhibitors (SSRIs) is, however, controversial in pain control. The present study was aimed at evaluating the efficacy of an SSRI,...

  • Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic... Anderson, I.M.; Tomenson, B.M. // BMJ: British Medical Journal (International Edition);6/3/95, Vol. 310 Issue 6992, p1433 

    Assesses treatment discontinuation rates with serotonin reuptake inhibitors compared with tricyclic antidepressants. Results of the meta-analysis of randomized controlled trials; Difference in toleration levels.

  • Use of SSRIs, SNRIs increasing in Northern Italy.  // PharmacoEconomics & Outcomes News;8/24/2013, Issue 685, p6 

    The article discusses a study conducted in Emilia Romagna, Italy, which found that the use of serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor antidepressants has significantly increased from 2006 to 2011.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics